NCT01433068View on ClinicalTrials.gov

NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Extremity

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

February 28, 2015

Conditions
Adult Soft Tissue Sarcoma
Interventions
DEVICE

NBTXR3

One intratumor implantation by injection

Trial Locations (2)

33076

Institut Bergonie, Bordeaux

94805

Institut Gustave Roussy, Villejuif

Sponsors

Lead Sponsor

Nanobiotix
All Listed Sponsors
lead

Nanobiotix

INDUSTRY

NCT01433068 - NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Extremity | Biotech Hunter | Biotech Hunter